Allergic bronchopulmonary aspergillosis - CHEST Publications ...

148 De Beule K, De Doncker P, Cauwenbergh G, et al. The
treatment of aspergillosis and aspergilloma with itraconazole,
clinical results of an open international study (1982–
1987). Mycoses 1988; 31:476–485
149 Mannes GP, van der Heide S, van Aalderen WM, et al.
Itraconazole and allergic bronchopulmonary aspergillosis in
twin brothers with cystic fibrosis. Lancet 1993; 341:492
150 Pacheco A, Martin JA, Cuevas M. Serologic response to
itraconazole in allergic bronchopulmonary aspergillosis.
Chest 1993; 103:980–981
151 Germaud P, Tuchais E. Allergic bronchopulmonary aspergillosis
treated with itraconazole. Chest 1995; 107:883
152 Nikaido Y, Nagata N, Yamamoto T, et al. A case of allergic
bronchopulmonary aspergillosis successfully treated with
itraconazole. Respir Med 1998; 92:118–119
153 Nepomuceno IB, Esrig S, Moss RB. Allergic bronchopulmonary
aspergillosis in cystic fibrosis: role of atopy and
response to itraconazole. Chest 1999; 115:364–370
154 Salez F, Brichet A, Desurmont S, et al. Effects of itraconazole
therapy in allergic bronchopulmonary aspergillosis.
Chest 1999; 116:1665–1668
155 Suzuki M, Sugiyama Y, Kitamura S. A case of allergic
bronchopulmonary aspergillosis refractory to the corticosteroid
therapy and successfully treated by itraconazole. Japanese
J Chest Dis 1999; 58:770–775
156 Stevens DA, Schwartz HJ, Lee JY, et al. A randomized trial
of itraconazole in allergic bronchopulmonary aspergillosis.
N Engl J Med 2000; 342:756–762
157 Skov M, Hoiby N, Koch C. Itraconazole treatment of
allergic bronchopulmonary aspergillosis in patients with
cystic fibrosis. Allergy 2002; 57:723–728
158 Kumar R, Singh P, Arora R, et al. Effect of itraconazole
therapy in allergic bronchopulmonary aspergillosis. Saudi
Med J 2003; 24:546–547
159 Morimoto T, Ohnishi H, Fujiyama R, et al. Allergic bronchopulmonary
aspergillosis successfully treated with itraconazole
and fluticasone. Japanese J Chest Dis 2003; 62:55–60
160 Ferrari M, Bodini I, Lo Cascio V. Rhabdomyolysis after the
administration of itraconazole to an asthmatic patient with
bronchopulmonary aspergillosis. Respiration 2004; 71:289–291
161 Wark PA, Gibson PG, Wilson AJ. Azoles for allergic bronchopulmonary
aspergillosis associated with asthma. Cochrane
Database Syst Rev (database online). Issue 3, 2004
162 Tucker RM, Haq Y, Denning DW, et al. Adverse events
associated with itraconazole in 189 patients on chronic
therapy. J Antimicrob Chemother 1990; 26:561–566
163 Lebrun-Vignes B, Archer VC, Diquet B, et al. Effect of
itraconazole on the pharmacokinetics of prednisolone and
methylprednisolone and cortisol secretion in healthy subjects.
Br J Clin Pharmacol 2001; 51:443–450
164 Main KM, Skov M, Sillesen IB, et al. Cushing’s syndrome
due to pharmacological interaction in a cystic fibrosis patient.
Acta Paediatr 2002; 91:1008–1011
165 Skov M, Main KM, Sillesen IB, et al. Iatrogenic adrenal
insufficiency as a side-effect of combined treatment of
itraconazole and budesonide. Eur Respir J 2002; 20:127–133
166 Laoudi Y, Paolini JB, Grimfed A, et al. Nebulised corticosteroid
and amphotericin B: an alternative treatment for
ABPA? Eur Respir J 2008; 31:908–909
167 van der Ent CK, Hoekstra H, Rijkers GT. Successful
treatment of allergic bronchopulmonary aspergillosis with
recombinant anti-IgE antibody. Thorax 2007; 62:276–277
168 Thomson JM, Wesley A, Byrnes CA, et al. Pulse intravenous
methylprednisolone for resistant allergic bronchopulmonary
aspergillosis in cystic fibrosis. Pediatr Pulmonol 2006; 41:
164–170
169 Mulliez P, Croxo C, Roy-Saint Georges F, et al. Allergic
broncho-pulmonary aspergillosis treated with voriconazole.
Rev Mal Respir 2006; 23:93–94
170 Bandres Gimeno R, Munoz Martinez MJ. Prolonged therapeutic
response to voriconazole in a case of allergic bronchopulmonary
aspergillosis. Arch Bronconeumol 2007; 43:
49–51
171 Erwin GE, Fitzgerald JE. Case report: allergic bronchopulmonary
aspergillosis and allergic fungal sinusitis successfully
treated with voriconazole. J Asthma 2007; 44:891–895
172 Mearns M, Young W, Batten J. Transient pulmonary infiltrations
in cystic fibrosis due to allergic aspergillosis. Thorax
1965; 20:385–392
173 Kraemer R, Delosea N, Ballinari P, et al. Effect of allergic
bronchopulmonary aspergillosis on lung function in children
with cystic fibrosis. Am J Respir Crit Care Med 2006;
174:1211–1220
174 Mastella G, Rainisio M, Harms HK, et al. Allergic bronchopulmonary
aspergillosis in cystic fibrosis: a European epidemiological
study; Epidemiologic Registry of Cystic Fibrosis.
Eur Respir J 2000; 16:464–471
175 de Almeida MB, Bussamra MH, Rodrigues JC. Allergic
bronchopulmonary aspergillosis in paediatric cystic fibrosis
patients. Paediatr Respir Rev 2006; 7:67–72
176 Knutsen AP, Hutcheson PS, Mueller KR, et al. Serum
immunoglobulins E and G anti-Aspergillus fumigatus antibody
in patients with cystic fibrosis who have allergic
bronchopulmonary aspergillosis. J Lab Clin Med 1990;
116:724–727
177 Laufer P, Fink JN, Bruns WT, et al. Allergic bronchopulmonary
aspergillosis in cystic fibrosis. J Allergy Clin Immunol
1984; 73:44–48
178 Mroueh S, Spock A. Allergic bronchopulmonary aspergillosis
in patients with cystic fibrosis. Chest 1994; 105:32–36
179 Nicolai T, Arleth S, Spaeth A, et al. Correlation of IgE
antibody titer to Aspergillus fumigatus with decreased lung
function in cystic fibrosis. Pediatr Pulmonol 1990; 8:12–15
180 Ritz N, Ammann RA, Casaulta Aebischer C, et al. Risk
factors for allergic bronchopulmonary aspergillosis and sensitization
to Aspergillus fumigatus in patients with cystic
fibrosis. Eur J Pediatr 2005; 164:577–582
181 Becker JW, Burke W, McDonald G, et al. Prevalence of
allergic bronchopulmonary aspergillosis and atopy in adult
patients with cystic fibrosis. Chest 1996; 109:1536–1540
182 Geller DE, Kaplowitz H, Light MJ, et al. Allergic bronchopulmonary
aspergillosis in cystic fibrosis: reported prevalence,
regional distribution, and patient characteristics; Scientific
Advisory Group, Investigators, and Coordinators of
the Epidemiologic Study of Cystic Fibrosis. Chest 1999;
116:639–646
183 Skov M, McKay K, Koch C, et al. Prevalence of allergic
bronchopulmonary aspergillosis in cystic fibrosis in an area
with a high frequency of atopy. Respir Med 2005; 99:887–
893
184 Mearns M, Longbottom J, Batten J. Precipitating antibodies
to Aspergillus fumigatus in cystic fibrosis. Lancet 1967;
1:538–539
185 Allan JD, Moss AD, Wallwork JC, et al. Immediate hypersensitivity
in patients with cystic fibrosis. Clin Allergy 1975;
5:255–261
186 Silverman M, Hobbs FD, Gordon IR, et al. Cystic fibrosis,
atopy, and airways lability. Arch Dis Child 1978; 53:873–877
187 Nelson LA, Callerame ML, Schwartz RH. Aspergillosis and
atopy in cystic fibrosis. Am Rev Respir Dis 1979; 120:863–873
188 Feanny S, Forsyth S, Corey M, et al. Allergic bronchopulmonary
aspergillosis in cystic fibrosis: a secretory immune response
to a colonizing organism. Ann Allergy 1988; 60:64–68
189 Schonheyder H, Jensen T, Hoiby N, et al. Clinical and
824 Global Medicine
Downloaded From: http://jupcvss.chestpubs.org/ on 08/01/2013